Lost your password?

Blogs about: 5 Ht1a

Featured Blog

Wyeth publish series of 5-HT1A Receptor/5-HT transporter inhibiors

crimsoncanary wrote 1 year ago: Wyeth have published a series of dual 5-HT1A /5-HT transporter inhibitors … more →

Tags: 5HT1A, Research, Wyeth, Preclinical

Recordati publish series of 5-HT1A Full Agonists

crimsoncanary wrote 1 year ago: Redordati have published a series of 1,4-dioxane 5-HT1A Full Agonists that are structurally related … more →

Tags: agonist, Research, Preclinical, recordati

OSI initiate Phase I trial of PSN602 for Obesity

crimsoncanary wrote 1 year ago: OSI Pharmaceuticals have initiated a Phase I trial of its dual serotonin and norepinephrine reuptake … more →

Tags: GPCR, agonist, 5HT1A, Phase I, OSI, PSN602, PSN-602

OSI present data on dual 5-HT1A agonist/Monoamine reuptake inhibitor

crimsoncanary wrote 1 year ago: OSI have presented preclinical data on its dual 5-HT1A agonist/Monoamine reuptake inhibitor PSN602 w … more →

Tags: GPCR, agonist, 5HT1A, OSI, Preclinical

PsychoGenics 5-HT1A/B receptor agonist eltoprazine shows efficacry in ADHD

crimsoncanary wrote 1 year ago: Phase IIa data released by PsychoGenics show its lead partial 5-HT1A – 5-HT1B receptor agonist eltop … more →

Tags: GPCR, agonist, 5HT1A, PsychoGenics, 5HT1B, 5-HT1B, eltoprazine

Seroquel approved for Maintenance Treatment in Bipolar Disorder

crimsoncanary wrote 1 year ago: The FDA has approved Seroquel (quetiapine fumarate) for the maintenance treatment of patients with b … more →

Tags: GPCR, Antagonist, 5HT2, 5-HT2, AstraZeneca, Histamine H1, Dopamine D2, 5HT1A, Dopamine D1

AstraZeneca submit sNDA for Seroquel XR in GAD

crimsoncanary wrote 1 year ago: AstraZeneca have submitted a supplemental NDA for Seroquel XR for the Treatment of Generalised Anxie … more →

Tags: GPCR, Antagonist, 5HT2, 5-HT2, AstraZeneca, Histamine H1, Dopamine D2, 5HT1A, Dopamine D1


Have your say. Start a blog.

See our free features →

Related Tags
All →

Follow this tag via RSS